Corvus Pharmaceuticals Inc (CRVS)

Operating Cash Flow (Statement)

-$15.40M

Quarterly · Period ending: · USD

CRVS logo

CRVS Operating Cash Flow (Statement)

Latest reported-$15.40M
CRVS Quarterly Cash from Operations (-$104.73K → -$15.40M)
High-resolution chart · PNG

CRVS operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-15,398,000
-10,374,000
-9,191,000
-9,566,000
-5,777,000
-8,263,000
-8,465,000
-6,321,000
-5,481,000
-5,157,000
-5,167,000
-5,434,000
-5,223,000
-8,111,000
-7,547,000
-6,929,000
-6,123,000
-6,424,000
-6,856,000
-8,425,000
-12,647,000
-8,787,000
-8,207,000
-7,732,000
-9,486,000
-9,353,000
-8,510,000
-10,607,000
-9,214,000
-8,990,000
-8,257,000
-10,797,000
-10,889,000
-11,045,000
-10,979,000
-10,774,000
-11,711,000
-12,748,000
-9,407,000
-6,685,000
-6,129,000
-5,636,000
-3,938,000
-3,352,000
-1,714,000
-2,324,000
-104,727
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.